Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             95 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters Bandoh, T.
 2004
 14 Supplement 3 p. 471-478
8 p.
 artikel
2 Alterations in QT dispersion in medicated schizophrenia patients following electroconvulsive therapy Nahshoni, Eitan
 2004
 14 Supplement 3 p. 121-125
5 p.
 artikel
3 A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia Bhanji, Nadeem H.
 2004
 14 Supplement 3 p. 87-92
6 p.
 artikel
4 Atypical antipsychotics and the relevance of glutamate and serotonin van der Heijden, F.M.M.A.
 2004
 14 Supplement 3 p. 259-265
7 p.
 artikel
5 Cerebrospinal neuropeptide Y and substance P in suicide attempters during long-term antidepressant treatment Olsson, Annica
 2004
 14 Supplement 3 p. 479-485
7 p.
 artikel
6 Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses Papakostas, George I.
 2004
 14 Supplement 3 p. 135-142
8 p.
 artikel
7 C.04.03 Newer pharmacological options for mania andmaintenance therapy Viele, E.
 2004
 14 Supplement 3 p. S402-S403
2 p.
 artikel
8 Corrigendum to “Gender in obsessive–compulsive disorder: clinical and genetic findings” [Eur. Neuropsychopharmacol. 14/2 (2004) 105–113] Lochner, Christine
 2004
 14 Supplement 3 p. 437-445
9 p.
 artikel
9 Corrigendum to “Omega-3 fatty acids in major depressive disorder A preliminary double-blind, placebo-controlled trial” [Eur. Neuropsychoparmacol. 13 (2003) 267–271] Su, Kuan-Pin
 2004
 14 Supplement 3 p. 173-
1 p.
 artikel
10 C.16.04 Pregabalin: From molecule to medicine Kavoussi, R.
 2004
 14 Supplement 3 p. S413-
1 p.
 artikel
11 Editorial Board 2004
 14 Supplement 3 p. IFC-
1 p.
 artikel
12 Effects of acute and repeated administration of a cholinesterase inhibitor on timing behaviour Bouger, Pascale C
 2004
 14 Supplement 3 p. 285-294
10 p.
 artikel
13 Effects of 5-HT1B receptor ligands microinjected into the ventral tegmental area on the locomotor and sensitizating effects of cocaine in rats Przegaliński, Edmund
 2004
 14 Supplement 3 p. 217-225
9 p.
 artikel
14 Effects of lipopolysaccharide and chlorpromazine on glucocorticoid receptor-mediated gene transcription and immunoreactivity: a possible involvement of p38-MAP kinase Basta-Kaim, Agnieszka
 2004
 14 Supplement 3 p. 521-528
8 p.
 artikel
15 GABAergic system and imipramine-induced impairment of memory retention in rats Zarrindast, M.R
 2004
 14 Supplement 3 p. 59-64
6 p.
 artikel
16 Gender in obsessive–compulsive disorder: clinical and genetic findings Lochner, Christine
 2004
 14 Supplement 3 p. 105-113
9 p.
 artikel
17 Influence of the combined treatment of LY 300164 (an AMPA/kainate receptor antagonist) with adenosine receptor agonists on the electroconvulsive threshold in mice Borowicz, K.K.
 2004
 14 Supplement 3 p. 407-412
6 p.
 artikel
18 Intracerebroventricular injection of trazodone produces 5-HT receptor subtype mediated anti-nociception at the supraspinal and spinal levels Zhang, Rihui
 2004
 14 Supplement 3 p. 419-424
6 p.
 artikel
19 Keyword index 2004
 14 Supplement 3 p. S81-S82
2 p.
 artikel
20 Neuroplasticity: from MRI to depressive symptoms Fossati, Philippe
 2004
 14 Supplement 3 p. S503-S510
8 p.
 artikel
21 Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test Harkin, Andrew
 2004
 14 Supplement 3 p. 274-281
8 p.
 artikel
22 P.3.12 Abnormalities of corpus callosum in schizophrenia: a diffusion-weighted MRI study Brambilla, P.
 2004
 14 Supplement 3 p. S54-S55
2 p.
 artikel
23 P3.044 Alttered 5HT1A binding in panic disorderdemonstrated by positron emission tomography Nash, J.R.
 2004
 14 Supplement 3 p. S322-S323
2 p.
 artikel
24 P.2.043 A new competitive ligand of 5-HT3 receptors Vitalis, B.
 2004
 14 Supplement 3 p. S250-S251
2 p.
 artikel
25 P.3.003 A randomized, double-blind, 8-week comparison of venlafaxine XR and placebo in out-patients with Generalized Anxiety Disorder (GAD) Kogeorgos, J.
 2004
 14 Supplement 3 p. S304-
1 p.
 artikel
26 P.2.132 A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United Kingdom Cavazzoni, P.
 2004
 14 Supplement 3 p. S290-S291
2 p.
 artikel
27 P.6.051 Association between seasonal mood variationand G-protein beta 3 nt polymorphism in a healthy young population Lee, H.J.
 2004
 14 Supplement 3 p. S378-
1 p.
 artikel
28 P.1.037 A study for clinical guideline of hypothyroidism during lithium maintenance therapy Yoon, D.I.
 2004
 14 Supplement 3 p. S189-
1 p.
 artikel
29 P.2.057 Atypical antipsychotics, prolactin, cholesteroland bone mineral density in patients with chronic schizophrenia — a preliminary report Won, S.H.
 2004
 14 Supplement 3 p. S257-
1 p.
 artikel
30 P.6.009 Bright light treatment in anorexia nervosa Janas-Kozik, M.
 2004
 14 Supplement 3 p. S360-
1 p.
 artikel
31 P.2.146 Clozapine and haloperidol prevents altered cytoskeletal organization in a stress oxidative cell culture model Ortega-Soto, H.A.
 2004
 14 Supplement 3 p. S297-
1 p.
 artikel
32 P.2.13 Co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex: implication for the neurobiology of psychiatric disorders Zuddas, A.
 2004
 14 Supplement 3 p. S30-S31
2 p.
 artikel
33 P.1.112 Correlation of depression ratings andremission cut-off scores on HAMD-17 and MADRS in double-blind, randomized comparisons of mirtazapine and SSRls Heukels, A.
 2004
 14 Supplement 3 p. S223-
1 p.
 artikel
34 P5.009 Defense mechanism and insight in relation toexecutive function of alcoholic patients Lee, K.S.
 2004
 14 Supplement 3 p. S343-
1 p.
 artikel
35 P.2.098 EEG abnormalities in patients treated with quetiapine Degner, D.
 2004
 14 Supplement 3 p. S275-
1 p.
 artikel
36 P4.031 Effects of cerebrum compositum and ubichinoncompositum in patients with postradiation on brain damage Zhavoronkova, L.A.
 2004
 14 Supplement 3 p. S335-S336
2 p.
 artikel
37 P.1.120 Effects of Mice daily 3 h maternal separations on behaviour, plasma corticosterone and brain monoamines in adult female rats Arborelius, L.
 2004
 14 Supplement 3 p. S227-
1 p.
 artikel
38 P.3.017 Elevated premenstrual serum cholesterollevels in women with premenstrual dysphoric disorder Liu, C.Y.
 2004
 14 Supplement 3 p. S311-
1 p.
 artikel
39 P.1.127 Evidence for antidepressant- and anxiolytic-like activities of melatonin and agomelatine in animal models Gruca, P.
 2004
 14 Supplement 3 p. S230-
1 p.
 artikel
40 P.2.30 Evidence for reduced anxiety in mice lacking CCK2 receptors Raud, S.
 2004
 14 Supplement 3 p. S43-
1 p.
 artikel
41 P.6.023 Experience of rearing circumstances in relation to course of illness in patients with therapy-refractory affective disorders Ehnvall, A.
 2004
 14 Supplement 3 p. S366-S367
2 p.
 artikel
42 P.2.011 Factors related to weight gain in patients withschizophrenia treated with serotonin-dopamine antagonists Jang, W.S.J.
 2004
 14 Supplement 3 p. S237-
1 p.
 artikel
43 P.3.027 Fluoxetine in the treatment of combat relatedPTSD: A subanalysis of a placebo-controlled trial of Bosnian, Croatian and Serbian veterans of the war in the former Yugoslavia (1992–1995) Martenyi, F.
 2004
 14 Supplement 3 p. S315-
1 p.
 artikel
44 P.1.023 Frontal cerebral perfusion after nortriptyline treatment versus citalopram treatment in elderly major depression: A 12-month follow-up control study Navarro, V.
 2004
 14 Supplement 3 p. S184-
1 p.
 artikel
45 P4.014 Galantamine improves attention in patientswith mild to moderate Alzheimer's disease Sohwalen, S.
 2004
 14 Supplement 3 p. S328-S329
2 p.
 artikel
46 P.2.026 Glucose and cholesterol level changes in patients treated with atypical ion therapy and or valproic acid combination therapy Park, D.B.
 2004
 14 Supplement 3 p. S242-S243
2 p.
 artikel
47 P.4.16 GSK-3β in cerebrospinal fluid of schizophrenic patients Kozlovsky, N.
 2004
 14 Supplement 3 p. S74-S75
2 p.
 artikel
48 P5.000 Haloperidol reduces excessive attention onheroin cues in abstinent heroin dependent patients Franken, I.H.A.
 2004
 14 Supplement 3 p. S342-
1 p.
 artikel
49 P5.005 Influence of adenosine A2A receptor agonist (CGS 21680) and antagonist (MSX-3) on the locomotor and sensitizing effects of cocaine Filip, M.
 2004
 14 Supplement 3 p. S341-
1 p.
 artikel
50 P.1.18 Inositol monophosphatase, 3′-phosphoadenosine 5′-phosphate phosophatase and glycogen synthase kinase-3 are less active in human brain than rat brain Shaltiel, G.
 2004
 14 Supplement 3 p. S16-S17
2 p.
 artikel
51 P.1.04 Interactions of GIPC with dopamine D2, D3 but not D4 receptors define a novel mode of regulation of G protein-coupled receptors Jeanneteau, F.
 2004
 14 Supplement 3 p. S5-
1 p.
 artikel
52 P.1.054 Interactions of vascular risk/disease andapolipoprotein E4 on depression in van older Korean population Kim, J.M.
 2004
 14 Supplement 3 p. S196-
1 p.
 artikel
53 P.1.099 Intracellular CAMP levels regulate the accumulation of lithium in neuronal cells Montezinho, L.P.
 2004
 14 Supplement 3 p. S217-
1 p.
 artikel
54 P.6671 In vivo electrophysiological study of the effects of escitalopram on the rat serotonergic neurotransmission El Mansari, M.
 2004
 14 Supplement 3 p. S387-
1 p.
 artikel
55 P.2.074 Is substance use high among patients withschizophrenia in Turkey? Akvardar, Y.
 2004
 14 Supplement 3 p. S264-S265
2 p.
 artikel
56 P.6.085 Modified behavioral test for estimation of malemice sexual motivation Amikishieva, A.V.
 2004
 14 Supplement 3 p. S392-S393
2 p.
 artikel
57 P.3.030 Monotherapy with benzodiazepines or SSRIsversus combined treatment in a sample of primary care patients with panic disorder Maki, K.M.
 2004
 14 Supplement 3 p. S316-S317
2 p.
 artikel
58 P.6.026 No association between the tryptophanhydroxylase gene polymorphism and major depressive disorders and antidepressant response Lee, M.S.
 2004
 14 Supplement 3 p. S368-
1 p.
 artikel
59 P.2.063 Pharmacological characterisation of SR 142801(osanetant) at clonal and native NK-3 receptors Thomas, D.R.
 2004
 14 Supplement 3 p. S259-S260
2 p.
 artikel
60 P4.017 Proton magnetic resonance spectroscopy(1HMRS) in the evaluation of brain metabolites changes in dementia with Lewy bodies and Alzheimer's disease Magiereld, R.
 2004
 14 Supplement 3 p. S329-S330
2 p.
 artikel
61 P.2.037 Reducing long term physical health risks associated with severe mental illness through a weight management programme: 3 year results Pendlebury, I.
 2004
 14 Supplement 3 p. S248-
1 p.
 artikel
62 P.1.085 Response to maintenance therapy based on history of previous lithium experience Young, A.H.
 2004
 14 Supplement 3 p. S210-
1 p.
 artikel
63 P2.101 Risperidone prevents relapses of disruptive behavioral disorders in children and adolescents of average intelligence: A 6-month trial of risperidone versus placebo Reyes-Harde, M.
 2004
 14 Supplement 3 p. S276-S277
2 p.
 artikel
64 P.2.094 Risperidone reduces symptoms of psychosisin Alzheimer's Disease: Results from 3 double-blind controlled clinical trials De Deyn, P.P.
 2004
 14 Supplement 3 p. S274-
1 p.
 artikel
65 P.2.129 Safety and toleraty of anti psychotics inchildren and adolescents: Preliminary results of a longitudinal study Laita, P.
 2004
 14 Supplement 3 p. S289-
1 p.
 artikel
66 P.6.057 Serum BDNF levels in conversion disorder:A comparative study with depression Deveci, A.
 2004
 14 Supplement 3 p. S380-
1 p.
 artikel
67 P.5.023 Substance use disorder in psychiatric inpatient Moon, S.W.
 2004
 14 Supplement 3 p. S349-
1 p.
 artikel
68 P.2.084 Switching patients with schizophrenia andantipsychotic-related metabolic disturbances to ziprasidone Montes, J.M.
 2004
 14 Supplement 3 p. S269-
1 p.
 artikel
69 P.6.054 The antinociceptive effect of oxcarbazepine in a rat model of inflammatory hyperalgesia Tomic, M.
 2004
 14 Supplement 3 p. S379-
1 p.
 artikel
70 P.2.073 The effect of MK-801 on the phosphorylationof GSK-3 beta in the rat frontal cortex Kim, Y.S.
 2004
 14 Supplement 3 p. S264-
1 p.
 artikel
71 P.3.15 The effect of typical and atypical neuroleptics on working memory in schizophrenic patients Libera, U.
 2004
 14 Supplement 3 p. S57-
1 p.
 artikel
72 P2.008 The effects of milnacipran on sleep indepressed patients: A polygraphic study with additional subjective assessment Lemoine, P.
 2004
 14 Supplement 3 p. S235-S236
2 p.
 artikel
73 P.2.060 The efficacy of risperidone in the managementof attempted suicide in patients with schizophrenia Barak, Y.
 2004
 14 Supplement 3 p. S258-S259
2 p.
 artikel
74 P.6.088 The influence of food-derived mother-dependent peptide beta-casomorphin-7 on mother-dependent albino rat pups behaviour Dubynin, V.A.
 2004
 14 Supplement 3 p. S394-
1 p.
 artikel
75 P.1.102 The relationship of the brain metabolism and the duration of illness in patients with major depressive disorder: Preliminary study Nam, Y.Y.
 2004
 14 Supplement 3 p. S218-
1 p.
 artikel
76 P.2.115 The schizophrenia quality of life scale (SOL)42-item short form (SOL-42): Conceptual framework and item selection Martin, P.
 2004
 14 Supplement 3 p. S283-
1 p.
 artikel
77 P.6.040 Time of hospitalization in mania using atypicalversus conventional antipsychotics Mahia, M.C. Garcia
 2004
 14 Supplement 3 p. S373-
1 p.
 artikel
78 P.1.020 ucb 46331, a new putative antidepressant agent: Efficacy in animal models of depression and anxiety Drieu La Rochelle, C.
 2004
 14 Supplement 3 p. S182-S183
2 p.
 artikel
79 P.1.066 Vagus nerve stimulation (VNS): An alternativefor maintenance ECT? Sorel, R.
 2004
 14 Supplement 3 p. S202-S203
2 p.
 artikel
80 P.1.010 Vigilance and driving skills in healthyvolunteers — effect of the dual-action antidepressant, milnacipran Pancani, E.
 2004
 14 Supplement 3 p. S178-S179
2 p.
 artikel
81 P.1.071 Which clinical and psychosocial factorspredictit response to prophylactic lithium in bipolar disorders? Kleindienst, N.
 2004
 14 Supplement 3 p. S204-
1 p.
 artikel
82 S.4.06 An association study of dopaminergic genes in a sample of 283 Dutch schizophrenic patients Hoogendoorn, M.L.C.
 2004
 14 Supplement 3 p. S67-
1 p.
 artikel
83 S.18.03 An evidence-based approach to reducing the risk of suicide in schizophrenia Meltzer, H.Y.
 2004
 14 Supplement 3 p. S145-S146
2 p.
 artikel
84 S.4.02 Dopamine 3 (D3) receptors genetic variants: influence in schizophrenia and antipsychotic response Clark, D.
 2004
 14 Supplement 3 p. S64-S65
2 p.
 artikel
85 S.11.04 Endocannabinoids — intrepid defenders of the nervous system Mechoulam, R.
 2004
 14 Supplement 3 p. S134-S135
2 p.
 artikel
86 S.27.05 Genes and oxidative stress Grünblattl, E.
 2004
 14 Supplement 3 p. S168-S169
2 p.
 artikel
87 S.07.02 Identification of GABAA receptor subtypesinvolved in tolerance against the sedative action of diazepam van Rijnsoever, C.
 2004
 14 Supplement 3 p. S124-S125
2 p.
 artikel
88 S.23.02 Interaction between caffeine and the dopaminergic system Simola, N.
 2004
 14 Supplement 3 p. S157-S158
2 p.
 artikel
89 S.02.04 Lewy body disease: How are dementiawith Lewy bodies and Parkinson's disease dementia related? Perry, E.K.
 2004
 14 Supplement 3 p. S113-S114
2 p.
 artikel
90 S.22.01 Linking the biology, phenomenology and pharmacology of psychosis — a feasible project or just a delusion Kapur, S.
 2004
 14 Supplement 3 p. S155-
1 p.
 artikel
91 S.2.1 Neuromodulators at the behavioral level Ögren, S.O.
 2004
 14 Supplement 3 p. S19-S20
2 p.
 artikel
92 S.13.02 Omega-3 fatty acid treatment in depression Puri, B.K.
 2004
 14 Supplement 3 p. S135-S136
2 p.
 artikel
93 S.13.05 Peptide approaches in the treatment of major depression — lack of efficacy of the substance P (neurokinin1 receptor) antagonist aprepitant Montgomery, S.A.
 2004
 14 Supplement 3 p. S136-S137
2 p.
 artikel
94 The phenotypic spectra of bipolar disorder Alda, Martin
 2004
 14 Supplement 3 p. S94-S99
6 p.
 artikel
95 Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram Wilson, S.J.
 2004
 14 Supplement 3 p. 367-372
6 p.
 artikel
                             95 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland